Vaccination against pneumococcal infections in adults

The following key issues of pneumococcal infection prophylaxis were discussed during the expert council: incidence rates of community-acquired pneumococcal pneumonia and other pneumococcal infections, local epidemiological data, increases in antimicrobial resistance and pneumococcal serotypes substi...

Full description

Bibliographic Details
Published in:Клиническая микробиология и антимикробная химиотерапия
Main Authors: Kozlov R.S., Avdeev S.N., Briko N.I., Bilichenko T.N., Kostinov M.P., Sidorenko S.V., Kharit S.M., Sinopalnikov A.I., Zaitsev A.A., Shubin I.V., Demko I.V., Ignatova G.L., Rachina S.A., Feldblum I.V.
Format: Article
Language:Russian
Published: Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy 2018-02-01
Subjects:
pneumococcal infection
vaccines
adults
pneumococcal polysaccharide vaccine
Online Access:https://cmac-journal.ru/publication/2018/1/cmac-2018-t20-n1-p005/cmac-2018-t20-n1-p005.pdf
Description
Summary:The following key issues of pneumococcal infection prophylaxis were discussed during the expert council: incidence rates of community-acquired pneumococcal pneumonia and other pneumococcal infections, local epidemiological data, increases in antimicrobial resistance and pneumococcal serotypes substitution, current international and Russian clinical guidelines, practical approaches, and pneumococcal vaccination coverage of adult population in the Russian Federation. The agreement between the experts about a need to distinguish the use of conjugate vaccines and polysaccharide vaccines in different subpopulations has been achieved.
ISSN:1684-4386
2686-9586

Similar Items